May 26, 2020
This article discusses opportunities, challenges and best practices in leveraging infrastructure excellence and AI to unlock the value of early or inconclusive clinical trial data. The goal... driving stronger biomarker-based insights and decisions and helping to advance new cures and treatment approaches.
As we all know, data is increasingly king in our information-driven world and organisations that learn how to turn mega information into informed strategies are creating true sea changes in their industries. The opportunity to harness the power of data in new and exciting ways is also moving increasingly into life sciences.
By David Wang, Masha Hoffey and Dr Simone Sharma
If you'd like to view the original article then follow the link below:
You can also download the original article pdf here:
For more information on Drug Discovery World, head to: